Coronary stenting does not benefit patients with severe left ventricular dysfunction

Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospitalization in patients with severe left ventricular dysfunction and extensive coronary artery disease, according to late breaking research presented in a Hot Line session on 27 August at ESC Congress 2022. Coronary artery disease is the most common cause of heart failure and is associated with poor survival […]

Continue reading »

Malaria booster vaccine continues to meet WHO-specified 75% efficacy goal

Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of the candidate malaria vaccine, R21/Matrix-M—which previously demonstrated high-level efficacy of 77% over the following 12 months in young west African children in 2021. In their findings (reported in The Lancet Infectious Diseases), they […]

Continue reading »

Centene Agrees to Pay Massachusetts $14 Million Over Medicaid Prescription Claims

Massachusetts has become the latest state to settle with health insurance giant Centene Corp. over allegations that it overbilled the state’s Medicaid program for pharmacy services, KHN has learned. Centene, the nation’s largest Medicaid managed-care insurer, will pay $14.2 million, according to Massachusetts Attorney General Maura Healey. An official announcement is expected later Thursday. “This settlement is a significant result […]

Continue reading »

Pilot program intends to address inequities in accessing monkeypox vaccines

Today, local, state, and territorial health departments, as well as tribal governments and local non-governmental organizations, can partner together and begin submitting requests to access monkeypox vaccine through the recently announced Monkeypox Vaccine Equity Pilot Program. This new pilot program is intended to reach populations that may face barriers to monkeypox vaccination, which may include differences in language, location of […]

Continue reading »

FDA Approves Botox Challenger Daxxify for Frown Lines

The US Food and Drug Administration (FDA) has approved daxibotulinumtoxinA-lanm  injection (Daxxify) for the temporary improvement in the appearance of moderate to severe glabellar lines (frown lines) in adults. According to a company news release, Daxxify, an acetylcholine release inhibitor and neuromuscular blocking agent, is the first peptide-formulated, long-acting neuromodulator approved for this indication. The approval of Daxxify, manufactured by […]

Continue reading »

FDA Warns Against Cooking Chicken in NyQuil

The FDA has issued a warning against cooking chicken in NyQuil after a social media challenge that encouraged people to try it went viral. Called the “sleepy chicken challenge,” the trend tells people to cook chicken in NyQuil or similar over-the-counter cough and cold medications, which include ingredients such as acetaminophen, dextromethorphan and doxylamine. “The challenge sounds silly and unappetizing […]

Continue reading »
1 349 350 351 352 353 1,322